Granules India - Gurgaon
Gurgaon, Haryana
About Company
Contact Information
Website
Registered Address
City
Gurgaon
State
Haryana
Country
India
Business Information
Business Types
Manufacturer
API Supplier
Exporter
Manufacturing Units
1
Legal & Compliance
Certifications & Approvals
WHO-GMP
Not Certified
ISO
Not Certified
GMP
Not Certified
FSSAI
Not Certified
USFDA
Not Approved
EU-GMP
Not Certified
UK-MHRA
Not Approved
WHO Prequalified
No
PCD/Franchise Information
PCD Franchisor
No
Products
Total products: 21
| Product Name | Dosage Form | Composition | Therapeutic Category |
|---|---|---|---|
| API Type Synthetic chemistry Quality ICH Therapeutic Category Analgesic, Antipyretic Monograph Status USP-A, EP-A Granules Product Status Commercially Available Regulatory Filing/Technical Package US | Tablet | - | Analgesics |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Anti-ulcerative Monograph Status A Granules Product Status Not Available - DMF filled Regulatory Filing/Technical Package US DMF Innovator | Tablet | - | - |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Antibiotic Monograph Status NA Granules Product Status NA (Process validation under progress) Regulatory Filing/Technical Package US DMF I | Tablet | - | Antibiotics |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Anticancer Monograph Status IH Granules Product Status Commercially Available Regulatory Filing/Technical Package US DMF Innovator Brands | Tablet | - | - |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Anticonvulsant Monograph Status A Granules Product Status Commercially Not Available Regulatory Filing/Technical Package US DMF Innovator | Tablet | - | - |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Antidepressant Monograph Status A Granules Product Status Commercially Available Regulatory Filing/Technical Package US DMF Innovator Bran | Tablet | - | - |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Antifungal Monograph Status USP-A, EP-A Granules Product Status Commercially Not Available Regulatory Filing/Technical Package US DMF, CEP | Tablet | - | Antifungals |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Antihemorrhagics Monograph Status NA Granules Product Status Commercially Available Regulatory Filing/Technical Package US DMF Innovator B | Tablet | - | - |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Antihistamine Monograph Status A Granules Product Status Commercially Available Regulatory Filing/Technical Package US DMF Innovator Brand | Tablet | - | - |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Antihypertensive Monograph Status A Granules Product Status Not Available - DMF Filied Regulatory Filing/Technical Package US DMF Innovato | Tablet | - | Antihypertensives |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Antiretroviral Monograph Status NA Granules Product Status Commercially Available Regulatory Filing/Technical Package US DMF Innovator Bra | Capsule | - | - |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Expectorant Monograph Status A Granules Product Status Commercially Available Regulatory Filing/Technical Package US DMF Innovator Brands | Tablet | - | - |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Muscle relaxant Monograph Status USP-A, EP-NA Granules Product Status Commercially Available Regulatory Filing/Technical Package US DMF, A | Tablet | - | - |
| Available dosage Form/Strength | Tablet | Tablet (12.5/25/50/75/100 mg), For Suspension,Oral... | - |
| Description Acetaminophen is a nonnarcotic analgesic and antipyretic drug. | - | - | Analgesics |
| Description Fluconazole is a synthetic triazole with antifungal activity. Fluconazole preferentially inhibits fungal cytochrome P-450 sterol C-14 alpha-demethylation, resulting in the accumulation of | - | - | Antifungals |
| Description Guaifenesin is a glyceryl guaiacolate with expectorant effects. Guaifenesin increases respiratory tract mucus secretions, acts as an irritant to gastric vagal receptors and recruits effere | - | - | Respiratory |
| Description Rifaximin is an orally administered, semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. Rifaximin binds to the beta-subunit of bacterial DNA-depe | - | - | Antibiotics |
| Dosage Form | Tablet | Tablet (12.5/25/50/75/100mg),For suspension(12.5/2... | - |
| Granules Product Status | Vial | - | - |
| Innovator Brands | Capsule | - | - |
Social Media
Company Status
Status
Active
Verification
Verified
Statistics
Profile Views
77
Total Inquiries
0